Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 160.7 CNY 0.19% Market Closed
Market Cap: ¥97B

Balance Sheet

Balance Sheet Decomposition
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Balance Sheet
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
27
83
197
241
274
262
219
163
240
228
350
413
1 182
1 251
1 472
1 706
2 085
2 782
4 232
2 412
7 084
2 412
1 159
1 483
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2 408
2 412
1 159
1 483
Cash Equivalents
27
83
197
241
274
262
219
163
240
228
350
413
1 182
1 251
1 472
1 706
2 085
2 782
4 232
2 412
4 677
0
0
0
Short-Term Investments
0
0
127
17
8
2
0
0
5
0
0
0
0
0
0
0
0
0
0
0
9
6 202
9 014
3 520
Total Receivables
84
65
44
45
70
115
116
136
138
134
143
154
175
209
365
477
640
617
777
738
875
1 037
1 183
1 089
Accounts Receivables
25
35
40
32
55
96
94
116
121
121
132
128
155
151
302
379
429
444
470
509
612
744
912
781
Other Receivables
59
30
4
13
15
19
22
20
17
13
11
26
20
58
63
98
211
173
307
229
263
293
271
308
Inventory
92
104
110
89
136
157
204
296
333
336
369
560
754
890
878
1 126
1 243
1 667
2 097
2 191
2 438
2 628
3 379
4 967
Other Current Assets
1
0
1
0
3
6
10
39
35
24
26
90
139
22
109
103
250
163
246
2 955
227
426
365
270
Total Current Assets
203
253
478
392
490
543
550
634
752
722
889
1 218
2 250
2 373
2 824
3 412
4 218
5 230
7 352
8 296
10 633
12 705
15 100
11 329
PP&E Net
67
68
83
85
92
84
161
170
191
183
199
242
283
340
318
281
274
257
263
494
613
677
826
1 820
PP&E Gross
67
68
83
85
92
84
161
170
191
183
199
242
283
340
318
281
274
257
263
494
613
677
826
1 820
Accumulated Depreciation
44
51
59
68
76
84
94
106
119
127
140
153
167
179
201
224
247
273
293
342
404
460
510
526
Intangible Assets
0
0
0
0
17
17
39
44
48
63
59
93
126
167
164
293
174
121
156
259
221
319
291
273
Goodwill
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
42
6
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
11
0
0
0
0
0
0
Long-Term Investments
0
5
34
82
94
108
220
216
286
471
411
664
423
745
673
943
871
932
930
1 008
826
697
646
3 920
Other Long-Term Assets
0
0
0
0
0
21
2
6
7
8
11
14
19
25
76
87
54
101
109
148
227
205
217
198
Other Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
42
6
0
0
0
0
0
0
Total Assets
270
N/A
326
+21%
595
+83%
559
-6%
694
+24%
773
+11%
971
+26%
1 071
+10%
1 285
+20%
1 447
+13%
1 569
+8%
2 231
+42%
3 101
+39%
3 650
+18%
4 055
+11%
5 038
+24%
5 648
+12%
6 658
+18%
8 811
+32%
10 206
+16%
12 521
+23%
14 604
+17%
17 080
+17%
17 540
+3%
Liabilities
Accounts Payable
2
18
3
1
50
58
69
69
62
87
66
76
72
67
87
147
162
191
206
222
322
363
506
436
Accrued Liabilities
10
17
22
6
13
18
25
41
34
29
49
25
38
59
63
52
56
88
124
169
375
401
714
506
Short-Term Debt
35
10
0
0
9
16
89
182
229
98
105
52
40
11
60
452
578
660
768
764
893
1 105
1 179
990
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
39
0
17
0
0
0
0
0
0
0
23
29
34
43
Other Current Liabilities
76
105
15
12
4
10
3
3
27
36
50
109
121
116
153
259
356
351
648
645
524
612
451
400
Total Current Liabilities
123
150
41
19
76
102
180
296
352
249
309
263
287
254
362
910
1 151
1 290
1 747
1 800
2 137
2 510
2 883
2 374
Long-Term Debt
0
20
0
0
0
0
0
0
20
30
0
314
298
299
299
300
0
0
0
0
87
109
143
213
Deferred Income Tax
0
0
0
0
0
8
31
11
28
51
42
67
13
66
47
32
30
15
48
47
75
61
30
0
Minority Interest
0
0
11
11
30
43
36
26
33
34
38
55
79
79
148
257
289
291
338
394
432
494
544
567
Other Liabilities
1
1
1
1
10
12
1
11
27
33
29
31
48
44
43
45
42
45
46
101
85
100
104
114
Total Liabilities
124
N/A
171
+38%
52
-70%
30
-42%
115
+283%
165
+43%
248
+50%
344
+39%
460
+34%
397
-14%
417
+5%
731
+75%
725
-1%
741
+2%
900
+21%
1 544
+72%
1 512
-2%
1 641
+9%
2 179
+33%
2 343
+8%
2 816
+20%
3 274
+16%
3 704
+13%
3 268
-12%
Equity
Common Stock
100
100
140
140
140
140
140
140
140
140
140
140
161
161
402
603
603
603
603
603
603
603
603
603
Retained Earnings
26
35
95
78
128
154
194
266
320
445
603
855
1 157
1 421
1 745
2 142
2 787
3 674
4 686
5 862
7 816
9 559
11 602
12 497
Additional Paid In Capital
20
20
308
310
310
316
391
322
367
467
410
508
1 028
1 029
808
638
638
638
1 084
1 085
1 086
1 094
1 095
1 095
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
203
73
75
88
Treasury Stock
0
0
0
0
0
2
2
2
2
2
2
2
16
16
14
14
14
14
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
46
313
214
125
122
116
258
312
3
1
2
11
Total Equity
146
N/A
155
+6%
543
+250%
528
-3%
578
+9%
608
+5%
723
+19%
726
+0%
825
+14%
1 050
+27%
1 151
+10%
1 500
+30%
2 377
+58%
2 908
+22%
3 155
+8%
3 493
+11%
4 136
+18%
5 016
+21%
6 631
+32%
7 862
+19%
9 705
+23%
11 330
+17%
13 376
+18%
14 272
+7%
Total Liabilities & Equity
270
N/A
326
+21%
595
+83%
559
-6%
694
+24%
773
+11%
971
+26%
1 071
+10%
1 285
+20%
1 447
+13%
1 569
+8%
2 231
+42%
3 101
+39%
3 650
+18%
4 055
+11%
5 038
+24%
5 648
+12%
6 658
+18%
8 811
+32%
10 206
+16%
12 521
+23%
14 604
+17%
17 080
+17%
17 540
+3%
Shares Outstanding
Common Shares Outstanding
414
414
580
580
580
573
573
573
573
573
573
573
544
544
603
603
603
603
603
603
603
603
603
603